Acupuncture and moxibustion for psoriasis: immunomodulatory mechanisms, clinical evidence, and emerging perspectives

Psoriasis is a chronic immune-mediated inflammatory disease with substantial physical and psychological burden. Biologic therapies targeting interleukin (IL)-17, IL-23, and tumor necrosis factor (TNF)-α have transformed management, yet prohibitive costs, adverse effects, paradoxical inflammatory reactions, and secondary loss of response sustain the need for safe, complementary approaches. Acupuncture and moxibustion, core Traditional Chinese Medicine modalities with over two millennia of clinical heritage, are increasingly studied as adjuncts for psoriasis. This narrative review synthesizes selected clinical studies identified through an earlier review, targeted PubMed searching, and reference checking, together with mechanistic evidence. Reported efficacy varies with modality and outcome definition. Some combination regimens have reported additional benefits, but the evidence is heterogeneous and the contribution of acupuncture is often difficult to isolate. In imiquimod-induced murine models, electroacupuncture reduces cutaneous T-cell infiltration and epidermal thickening, with substance P/neurokinin-1 receptor (SP/NK1R) signaling implicated in these effects; in a separate study, T helper 17 (Th17)/regulatory T (Treg) rebalancing and nuclear factor-κB (NF-κB) inhibition were observed with electroacupuncture alone and were more pronounced when combined with methotrexate. The cholinergic anti-inflammatory pathway, hypothalamic-pituitary-adrenal (HPA) axis modulation, and endogenous opioid release have been proposed as additional mechanisms, but their evidence derives mainly from other diseases and remains unconfirmed in psoriasis. Three emerging frontiers—the gut-skin axis, network pharmacology of acupoint-immune targets, and brain-skin axis neuroimaging—warrant further study. These observations and hypotheses position acupuncture as mechanistically plausible and clinically promising, yet validation through rigorous multicenter trials and multi-omics dissection of acupoint-immune networks remains essential.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1915431
Primary Topic
Acupuncture Treatment Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Acupuncture and moxibustion for psoriasis: immunomodulatory mechanisms, clinical evidence, and emerging perspectives

Hongmei Lyu, Zijie Tang, Yalin Lu, Qi Chen
1 links
Frontiers in Immunology
Acupuncture Treatment Research Studies
article

Acupuncture and moxibustion for psoriasis: immunomodulatory mechanisms, clinical evidence, and emerging perspectives

Hongmei Lyu, Zijie Tang, Yalin Lu, Qi Chen
article en

Abstract

Psoriasis is a chronic immune-mediated inflammatory disease with substantial physical and psychological burden. Biologic therapies targeting interleukin (IL)-17, IL-23, and tumor necrosis factor (TNF)-α have transformed management, yet prohibitive costs, adverse effects, paradoxical inflammatory reactions, and secondary loss of response sustain the need for safe, complementary approaches. Acupuncture and moxibustion, core Traditional Chinese Medicine modalities with over two millennia of clinical heritage, are increasingly studied as adjuncts for psoriasis. This narrative review synthesizes selected clinical studies identified through an earlier review, targeted PubMed searching, and reference checking, together with mechanistic evidence. Reported efficacy varies with modality and outcome definition. Some combination regimens have reported additional benefits, but the evidence is heterogeneous and the contribution of acupuncture is often difficult to isolate. In imiquimod-induced murine models, electroacupuncture reduces cutaneous T-cell infiltration and epidermal thickening, with substance P/neurokinin-1 receptor (SP/NK1R) signaling implicated in these effects; in a separate study, T helper 17 (Th17)/regulatory T (Treg) rebalancing and nuclear factor-κB (NF-κB) inhibition were observed with electroacupuncture alone and were more pronounced when combined with methotrexate. The cholinergic anti-inflammatory pathway, hypothalamic-pituitary-adrenal (HPA) axis modulation, and endogenous opioid release have been proposed as additional mechanisms, but their evidence derives mainly from other diseases and remains unconfirmed in psoriasis. Three emerging frontiers—the gut-skin axis, network pharmacology of acupoint-immune targets, and brain-skin axis neuroimaging—warrant further study. These observations and hypotheses position acupuncture as mechanistically plausible and clinically promising, yet validation through rigorous multicenter trials and multi-omics dissection of acupoint-immune networks remains essential.

Frontiers in ImmunologyVol. 17
Beijing University of Chinese Medicine (CN), Chinese PLA General Hospital (CN), First Affiliated Hospital of Chinese PLA General Hospital (CN), Air Force Medical University (CN)
Good health and well-being
Acupuncture Treatment Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon